India bolsters regulators to brace global competition
India is bolstering its regulatory bodies to global standards to become a world leader in drug discovery and innovative medical devices, a minister
India is bolstering its regulatory bodies to global standards to become a world leader in drug discovery and innovative medical devices, a minister
Adani Renewable Energy Holding Two, a wholly-owned subsidiary of Adani Green Energy, announced it has entered into a binding term sheet to acquire
Glenmark Pharmaceuticals, an Indian multinational firm, has introduced its heart failure drug in the country, according to a company statement.
Pharma major Lupin has received a ātentative approvalā, from the United States Food and Drug Administration (FDA), to market medicines used to treat
New research led by Duke researchers says that the SARS Cov-2 Ā virus can make the immune system attack the nerve cells in the
Skipping meals and eating meals too closely together may be linked with increased cardiovascular or mortality, researchers report.
The USFDA has granted Zydus Lifesciences Limited ātentative approvalā to market Levomilnacipran extended-release capsules in 20 mg, 40 mg, 80 mg, and 120
The Indian pharmaceutical industry is expected to witness ādecent growthā during the three-month period through 31 March 2023, mainly led by continued traction
Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.
he current treatment of cortical malformations in the anterior parts of the brain, or cerebrum, in vertebrates by its surgical removal to cure